Precision Probiotics

The emerging model of microbiome science focuses on targeted functionality—identifying the health problem, the microbial functions involved, and the strains that perform those functions—rather than general diversity or CFU count. A formula with better survival and targeted strain selection may be more effective than a high-dose formula with poor delivery. A complete multi-strain probiotic formula needs evidence as a formula, not only evidence for individual strains. Pendulum Therapeutics developed the first microbiome-based intervention for people with type 2 diabetes, targeting blood sugar through gut microbial function rather than a conventional drug. The probiotic industry historically developed products based on which microbes could be commercialized at scale, not which microbial functions addressed specific diseases. Pendulum received early strategic guidance to choose a specific disease target rather than presenting as a broad research and discovery company. Precision microbiome interventions aim to identify specific bacterial strains, understand their functions, combine them with substrates they need, and validate their effects with clinical-grade research. The article trea…